Dictionary of Cancer Terms
View in Spanish: Visilizumab
Visilizumab
A monoclonal antibody that binds to CD3 (a substance found on T-cells) and that is being studied as a treatment for graft-versus-host disease (GVHD). It belongs to the family of drugs called monoclonal antibodies.
Source: National Cancer Institute Dictionary of Cancer Terms, available at www.cancer.gov/dictionary.